NCT00053989 2020-02-10NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersRoswell Park Cancer InstitutePhase 2 Completed41 enrolled 13 charts
NCT00301834 2017-09-28Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic DisordersUniversity of California, San FranciscoPhase 2 Completed35 enrolled 11 charts
NCT00281879 2017-09-27Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerOHSU Knight Cancer InstitutePhase 2 Terminated200 enrolled 11 charts